Abgenix is a biopharmaceutical company
focused on the discovery, development & manufacture of human
therapeutic antibodies. The company's antibody development
platform includes a leading technology & state-of-the-art
manufacturing capabilities that enable the rapid generation,
selection & production of high affinity, fully human antibody
product candidates to a variety of disease targets. Abgenix
leverages its leadership position in human antibody technology
to build a diversified product portfolio through the
establishment of collaborations with multiple pharmaceutical &
biotechnology companies.
